Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Liposomal Drug Delivery Devices Global Market Report 2025
Request Sample Buy Now
Global Liposomal Drug Delivery Devices Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Liposomal Drug Delivery Devices Global Market Report 2025

By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Liposomal Drug Delivery Devices Market Overview

• Liposomal Drug Delivery Devices market size has reached to $4.89 billion in 2024

• Expected to grow to $8.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%

• Growth Driver: Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market

• Market Trend: Strategic Innovations In The Liposomal Drug Delivery Devices Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Liposomal Drug Delivery Devices Market?

Liposomal drug delivery devices are microscopic colloidal spheres that are used to deliver drug molecules to the site of action.

The main types of liposomal drug delivery devices are liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Liposomal doxorubicin is a kind of chemotherapy drug known as anthracycline wrapped up in a liposome. It slows or stops the increase of cancer cells by blocking an enzyme called topoisomerase. The applications included are fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy that are used in hospitals, diagnostic centers, ambulatory surgery centers/clinics, and others.

Liposomal Drug Delivery Devices Market 2025 - 2034

What Is The Liposomal Drug Delivery Devices Market Size 2025 And Growth Rate?

The liposomal drug delivery devices market size has grown rapidly in recent years. It will grow from $4.89 billion in 2024 to $5.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to drug delivery advancements, biomedical research, clinical validation, therapeutic applications, and biocompatibility enhancements.

What Is The Liposomal Drug Delivery Devices Market Growth Forecast?

The liposomal drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $8.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to targeted therapies expansion, clinical validation and trials, personalized medicine emphasis, combination therapies development, regulatory landscape changes. Major trends in the forecast period include biocompatible liposomal materials, innovations in delivery systems, application in oncology, combination therapies, customized liposome formulations.

The forecast of 12.2% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for phospholipid encapsulation materials and sterile vial filling systems, sourced from key regions such as France and Israel, which could lead to reduced targeted therapy options and increased costs for specialized cancer treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Liposomal Drug Delivery Devices Market Segmented?

1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types

2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy

3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users

Subsegments:

1) By Liposomal Doxorubicin: Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin

2) By Liposomal Paclitaxel: Conventional Liposomal Paclitaxel, PEGylated Liposomal Paclitaxel

3) By Liposomal Amphotericin B: Conventional Liposomal Amphotericin B, PEGylated Liposomal Amphotericin B

4) By Other Types: Liposomal Irinotecan, Liposomal Vincristine, Liposomal Cytarabine

Liposomal Drug Delivery Devices Market Driver: Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the liposomal drug delivery devices market during the forecast period. Liposomal drug delivery systems are used as targeted therapy for cancer treatment in radiation therapy, chemotherapy, and surgical resection. For instance, in June 2022, according to the data published by the Macmillan Cancer Support, a UK-based cancer charity, the number of people living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the rise in the cancer incidence rate globally is anticipated to boost the demand for the liposomal drug delivery devices market over the forthcoming years.

Liposomal Drug Delivery Devices Market Driver: Rising Healthcare Expenditure Fuels The Growth Of The Liposomal Drug Delivery Devices Market

The rising healthcare expenditure is expected to propel the growth of the liposomal drug delivery devices market going forward. The rise in healthcare expenditure can be attributed to several interconnected factors such as increased prevalence of chronic diseases, advancements in medical technology, rising drug prices, consumer expectations, insurance costs, etc. Healthcare expenditure encompasses a wide range of medical and healthcare-related costs, including expenses related to liposomal drug delivery devices. These expenditures cover various aspects of healthcare, including research, development, manufacturing, distribution, and utilization of medical technologies and devices like liposomal drug delivery systems. For instance, in July 2022, according to Peter G Foundation, a US-based consulting firm, both public and private spending on healthcare, are projected to climb from $4.4 trillion, or $13,413 per person, in 2022 to $7.2 trillion, or $20,425 per person, in 2031. Compared to the GDP, National Healthcare Expenditure (NHE) is expected to increase from 17.4% in 2022 to approximately 20 percent by 2031 due to healthcare cost escalation outpacing economic growth. Therefore, the rising healthcare expenditure is driving the growth of the liposomal drug delivery devices market.

Global Liposomal Drug Delivery Devices Market Major Players

Major companies operating in the liposomal drug delivery devices market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation

Global Liposomal Drug Delivery Devices Market Trend: Strategic Innovations In The Liposomal Drug Delivery Devices Market

Several big companies are undertaking various strategic initiatives such as new product development, which is likely to become a major trend in the liposomal drug delivery devices market. Various companies are coming together to develop liposomal drug delivery systems to expand their product portfolio and operations worldwide. For instance, in May 2024, Insmed, Inc., a US-based biotech company announced data from the ARISE study of ARIKAYCE (amikacin liposome inhalation suspension). ARIKAYCE-treated patients performed better than those in the comparator arm (a macrolide-based multi-drug regimen) as measured by the QOL-B instrument, with 43.8% of patients achieving an improvement in QOL-B respiratory score.

Global Liposomal Drug Delivery Devices Market Trend: Innovative Liposomal Nanostructures Enhance Patient Compliance In The Liposomal Drug Delivery Market

Major companies operating in the liposomal drug delivery market are introducing innovative products such as liposomal nanostructures to gain a competitive edge in the market Researchers have been working on developing liposomal nanostructures that can improve patient compliance by allowing less frequent doses while maintaining efficacy. For instance, in February 2022, according to National Center for biotechnology information, commercial nano-liposomal products, including Onivyde, Vyxeos, and Marqibo, which have been approved and are currently in use. Onivyde, Vyxeos, and Marqibo are all medications used in the treatment of cancer, specifically for certain types of leukemia or solid tumors. These medications play a crucial role in oncology by providing treatment options for specific types of cancer that may be resistant to conventional chemotherapy or require liposomal drug delivery.

Global Liposomal Drug Delivery Devices Market Trend: Innovative Liposomal Drug Delivery Enhances Patient Compliance And Oncology Treatment Options

Major companies operating in the liposomal drug delivery market are introducing innovative products such as hydrochloride liposome injection to gain a competitive edge in the market. Researchers have been working on developing liposomal nanostructures that can improve patient compliance by allowing less frequent doses while maintaining efficacy. For instance, in August 2024, Lupin Ltd., an India-based pharma company, launched Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL). The Doxorubicin Hydrochloride Liposome Injection had an estimated annual sales figure of approximately USD 40.9 million in the U.S. market as of June 2024. This positions Lupin strategically within the oncology segment as IT expands its portfolio to include this important cancer treatment option. Lupin's commitment to improving patient health outcomes is evident through this launch, as IT aims to provide effective treatment alternatives in a competitive pharmaceutical landscape.

Need data on a specific region in this market?
Request Customisation

Regional Outlook For The Global Liposomal Drug Delivery Devices Market

North America was the largest region in the liposomal drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global liposomal drug delivery devices market share. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Liposomal Drug Delivery Devices Market?

The liposomal drug delivery devices market consists of sales of instruments such as liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Liposomal Drug Delivery Devices Industry?

The liposomal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liposomal drug delivery devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Liposomal Drug Delivery Devices Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $5.34 billion
Revenue Forecast In 2034 $8.48 billion
Growth Rate CAGR of 12.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users Subsegments: 1) By Liposomal Doxorubicin: Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin
2) By Liposomal Paclitaxel: Conventional Liposomal Paclitaxel, PEGylated Liposomal Paclitaxel
3) By Liposomal Amphotericin B: Conventional Liposomal Amphotericin B, PEGylated Liposomal Amphotericin B
4) By Other Types: Liposomal Irinotecan, Liposomal Vincristine, Liposomal Cytarabine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Liposomal Drug Delivery Devices Market Characteristics

3. Liposomal Drug Delivery Devices Market Trends And Strategies

4. Liposomal Drug Delivery Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Liposomal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Liposomal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Liposomal Drug Delivery Devices Market Growth Rate Analysis

5.4. Global Liposomal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Liposomal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Liposomal Drug Delivery Devices Total Addressable Market (TAM)

6. Liposomal Drug Delivery Devices Market Segmentation

6.1. Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liposomal Doxorubicin

Liposomal Paclitaxel

Liposomal Amphotericin B

6.2. Global Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fungal Diseases

Cancer Therapy

Pain Management

Viral Vaccines

Photodynamic Therapy

6.3. Global Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Ambulatory Surgery Centers/Clinics

Other End Users

6.4. Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Doxorubicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Liposomal Doxorubicin

PEGylated Liposomal Doxorubicin

6.5. Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Paclitaxel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Liposomal Paclitaxel

PEGylated Liposomal Paclitaxel

6.6. Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Amphotericin B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Conventional Liposomal Amphotericin B

PEGylated Liposomal Amphotericin B

6.7. Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Other Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liposomal Irinotecan

Liposomal Vincristine

Liposomal Cytarabine

7. Liposomal Drug Delivery Devices Market Regional And Country Analysis

7.1. Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Liposomal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liposomal Drug Delivery Devices Market

8.1. Asia-Pacific Liposomal Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liposomal Drug Delivery Devices Market

9.1. China Liposomal Drug Delivery Devices Market Overview

9.2. China Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liposomal Drug Delivery Devices Market

10.1. India Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liposomal Drug Delivery Devices Market

11.1. Japan Liposomal Drug Delivery Devices Market Overview

11.2. Japan Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liposomal Drug Delivery Devices Market

12.1. Australia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liposomal Drug Delivery Devices Market

13.1. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liposomal Drug Delivery Devices Market

14.1. South Korea Liposomal Drug Delivery Devices Market Overview

14.2. South Korea Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liposomal Drug Delivery Devices Market

15.1. Western Europe Liposomal Drug Delivery Devices Market Overview

15.2. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liposomal Drug Delivery Devices Market

16.1. UK Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liposomal Drug Delivery Devices Market

17.1. Germany Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liposomal Drug Delivery Devices Market

18.1. France Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liposomal Drug Delivery Devices Market

19.1. Italy Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liposomal Drug Delivery Devices Market

20.1. Spain Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liposomal Drug Delivery Devices Market

21.1. Eastern Europe Liposomal Drug Delivery Devices Market Overview

21.2. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liposomal Drug Delivery Devices Market

22.1. Russia Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liposomal Drug Delivery Devices Market

23.1. North America Liposomal Drug Delivery Devices Market Overview

23.2. North America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liposomal Drug Delivery Devices Market

24.1. USA Liposomal Drug Delivery Devices Market Overview

24.2. USA Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liposomal Drug Delivery Devices Market

25.1. Canada Liposomal Drug Delivery Devices Market Overview

25.2. Canada Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liposomal Drug Delivery Devices Market

26.1. South America Liposomal Drug Delivery Devices Market Overview

26.2. South America Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liposomal Drug Delivery Devices Market

27.1. Brazil Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liposomal Drug Delivery Devices Market

28.1. Middle East Liposomal Drug Delivery Devices Market Overview

28.2. Middle East Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liposomal Drug Delivery Devices Market

29.1. Africa Liposomal Drug Delivery Devices Market Overview

29.2. Africa Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liposomal Drug Delivery Devices Market Competitive Landscape And Company Profiles

30.1. Liposomal Drug Delivery Devices Market Competitive Landscape

30.2. Liposomal Drug Delivery Devices Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Liposomal Drug Delivery Devices Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. Sun Pharmaceutical Industries Ltd.

31.3. CSPC Pharmaceutical Group Limited

31.4. Ipsen SA

31.5. Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd.

31.6. Nanomerics Ltd.

31.7. Luye Pharma Group Ltd.

31.8. Leadiant Biosciences Inc.

31.9. Pacira Biosciences Inc.

31.10. Nippon Kayaku Co. Ltd.

31.11. Celsion Corporation

31.12. Acrotech Biopharma Inc.

31.13. Aphios Pharma LLC

31.14. CytImmune Sciences Inc.

31.15. NanoSphere Health Sciences Inc.

32. Global Liposomal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liposomal Drug Delivery Devices Market

34. Recent Developments In The Liposomal Drug Delivery Devices Market

35. Liposomal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

35.1 Liposomal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities

35.2 Liposomal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities

35.3 Liposomal Drug Delivery Devices Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Doxorubicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Paclitaxel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Amphotericin B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Other Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Liposomal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Services Inc. Financial Performance
  • Table 80: Merck & Co. Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Gilead Sciences Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Doxorubicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Paclitaxel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Liposomal Amphotericin B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Liposomal Drug Delivery Devices Market, Sub-Segmentation Of Other Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Liposomal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Liposomal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Liposomal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Liposomal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Liposomal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Services Inc. Financial Performance
  • Figure 80: Merck & Co. Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Gilead Sciences Inc. Financial Performance

Thoracic Surgery Devices Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Thoracic Surgery Devices Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Tooth Filling Materials Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Tooth Filling Materials Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Tourniquet Cuffs Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Read More About Tourniquet Cuffs Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Ultrasound Transducer Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Ultrasound Transducer Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Read More About The global medical gloves market report offers strategic insights and market intelligence through 2025.

Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulator...

View Report

Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Su...

View Report

COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyn...

View Report

Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030...

View Report

Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD), By End-Use...

View Report

Sterilization Equipment And Disinfectants Market 2023 – By Product Type (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End Use (Hospitals And Clinics, Clinic...

View Report

Diagnostic Equipment Global Market Report 2022 – By Type (X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring And Diagnostic Devices, and Nu...

View Report

Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes), By Type Of Product( Plastics & Polymers, Chl...

View Report

Frequently Asked Questions

Liposomal drug delivery devices are microscopic colloidal spheres that are used to deliver drug molecules to the site of action. For further insights on this market, request a sample here

The market major growth driver - Global Increase In Cancer Cases Fuels Growth Of Liposomal Drug Delivery Devices Market. For further insights on this market, request a sample here

The liposomal drug delivery devices market size has grown strongly in recent years. It will grow from $4.89 billion in 2024 to $5.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to drug delivery advancements, biomedical research, clinical validation, therapeutic applications, and biocompatibility enhancements. The liposomal drug delivery devices market size is expected to see rapid growth in the next few years. It will grow to $8.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to targeted therapies expansion, clinical validation and trials, personalized medicine emphasis, combination therapies development, regulatory landscape changes. Major trends in the forecast period include biocompatible liposomal materials, innovations in delivery systems, application in oncology, combination therapies, customized liposome formulations. For further insights on this market, request a sample here

The liposomal drug delivery devicesmarket covered in this report is segmented –
1) By Type: Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types
2) By Application: Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy
3) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users Subsegments:
1) By Liposomal Doxorubicin: Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin
2) By Liposomal Paclitaxel: Conventional Liposomal Paclitaxel, PEGylated Liposomal Paclitaxel
3) By Liposomal Amphotericin B: Conventional Liposomal Amphotericin B, PEGylated Liposomal Amphotericin B
4) By Other Types: Liposomal Irinotecan, Liposomal Vincristine, Liposomal Cytarabine For further insights on this market, request a sample here

North America was the largest region in the liposomal drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global liposomal drug delivery devices market share. The regions covered in the liposomal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the liposomal drug delivery devices market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Ipsen SA, Shanghai Fudan Zhangjiang Bio-Pharmaceutical Co. Ltd., Nanomerics Ltd., Luye Pharma Group Ltd., Leadiant Biosciences Inc., Pacira Biosciences Inc., Nippon Kayaku Co. Ltd., Celsion Corporation, Acrotech Biopharma Inc., Aphios Pharma LLC, CytImmune Sciences Inc., NanoSphere Health Sciences Inc., Cel-Sci Corporation, Lipoid GmbH, Liposome Company Inc., Liposome Research Days Corporation, Taiwan Liposome Company, T&T Scientific Corporation . For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Liposomal Drug Delivery Devices Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top
\
Back to top